Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin in Impaired Glucose Tolerance
NCT00237250Phase 3Completed
- Sponsor
- Novartis
- Start
- Oct 2005
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vildagliptin in impaired glucose tolerance (IGT), sponsored by Novartis. Started Oct 2005; status: completed.
02
Drugs
vildagliptin
03
Conditions
impaired glucose tolerance (IGT)
Beyond the preview
Go deeper on NCT00237250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00237250.